Candesartan cilexetil 32 MG TB 90S
Ended Awarded
- Contract number
- SPE2DR26FL8RX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,542
Award facts
- Contract value 100% obligated
- $16,542.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $16,542.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies delivered through the DLA Medical Supply Chain, including brand-name and generic medications, vaccines, and specialized healthcare commodities. The SPE2DX prime contract vehicle enables AmerisourceBergen to supply pharmaceutical products to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Candesartan Cilexetil, a hypertension medication, exemplifies the company's role in fulfilling routine pharmaceutical needs within the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26FL8RX?
SPE2DR26FL8RX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FL8RX worth?
The government has obligated $16,542 on SPE2DR26FL8RX.
Is contract SPE2DR26FL8RX an order under another contract?
Yes. SPE2DR26FL8RX is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL8RX competed?
The extent of competition for SPE2DR26FL8RX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award